IPHA News
October 8, 2025
6,000 patients could benefit from €30 million for new medicines announced in Budget 2026 Minister’s commitment to adhering to the legislative timelines for new medicines decisions […]
September 29, 2025
IPHA welcomes the confirmation today (Tuesday 29th September) from the Minister for Health, Jennifer Carroll MacNeill TD, that the State will enter into formal talks on […]
August 21, 2025
Thursday 21st August 2025 IPHA notes the joint statement by the US and EU on tariffs today (Thursday), particularly the aspects dealing with pharmaceuticals. Some mitigation […]
July 23, 2025
IPHA launches report that highlights the Socio-Economic Value of Self-Care.
June 30, 2025
A record level of 98% of Healthcare Professionals have provided named transparency on www.transfersofvalue.ie IPHA member company investment in R&D increases significantly Since July 2016, and […]
June 20, 2025
IPHA response to Sinn Féin’s Healthcare (Transparent Payments) Bill 2022 as disclosure rates continue to rise. Disclosure rates to named healthcare professionals for 2023 was 96%; 2024 […]
June 16, 2025
Dublin, 16 June 2025 – The Irish Pharmaceutical Healthcare Association (IPHA) and cormeo, the newly established German based Pharma Tech holding company under Bertelsmann, announces its […]
May 20, 2025
20 May 2025 The Irish Pharmaceutical Healthcare Association (IPHA) welcomes encouraging progress in clinical trials activity in Ireland over the past year, as reported in its […]
May 7, 2025
Ireland continues to rank among the bottom of Western European countries when it comes to availability of newly licensed cancer treatments, according to a new report by data analysts IQVIA for EFPIA, the European pharmaceutical body.